Effects of FHL1 and P21 on hypoxia‑induced pulmonary vascular remodeling in neonatal rats

Du,Yanna; Fu,Jianhua; Yao,Li; Zhang,Dan; Liu,Na; Xue,Xindong

doi:10.3892/etm.2017.5055

Effects of FHL1 and P21 on hypoxia‑induced pulmonary vascular remodeling in neonatal rats

Authors:
- Yanna Du
- Jianhua Fu
- Li Yao
- Dan Zhang
- Na Liu
- Xindong Xue
View Affiliations

Affiliations: Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
Published online on: August 28, 2017 https://doi.org/10.3892/etm.2017.5055
Pages: 4245-4253
Copyright: © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous studies have demonstrated that altered expression levels of four and a half LIM domains 1 (FHL1) and P21 are necessary for hypoxia‑induced pulmonary vascular remodeling in both adult rats and human patients with idiopathic pulmonary arterial hypertension. However, whether FHL1 and P21 are present in the pulmonary artery and whether these proteins affect pulmonary vascular remodeling in hypoxia‑induced pulmonary hypertension (HPH) in neonatal rats remain unknown. The present study investigated the effects of altered FHL1 and P21 expression on pulmonary vascular remodeling in neonatal rats with HPH. A total of 32 newborn Sprague‑Dawley rats were exposed to hypoxia or room air for 7 or 14 days (n=8/subgroup). Parameters including the percentage of medial wall thickness (WT%), the percentage of medial wall area (WA%), right ventricular (RV) mean pressure, RV hypertrophy index (RVHI) and RV systolic pressure (RVSP) were measured to evaluate the development of HPH. Additionally, the expressions of FHL1 and P21 in the pulmonary artery smooth muscle cells (PASMCs) were measured by reverse transcription‑quantitative polymerase chain reaction, western blot analysis and immunohistochemical staining. WA%, WT%, RV mean pressure, RVHI and RVSP were significantly increased in the HPH model group when compared with the control group (P<0.01). The protein expression levels of FHL1 were significantly increased in the HPH group (P<0.05), while the mRNA and protein expression levels of P21 were significantly reduced (P<0.05). Pearson correlation analysis indicated that the protein expressions of FHL1 and P21 were correlated with WA% and WT% (all P<0.001), and that the protein expression of P21 was negatively correlated with that of FHL1 (P<0.01). The results indicated that the expressions of FHL1 and P21 were altered in the PASMCs of newborn rats with HPH. Furthermore, FHL1 and P21 may serve important roles in pulmonary vascular remodeling.

View Figures

View References

1	Jain A and McNamara PJ: Persistent pulmonary hypertension of the newborn: Advances in diagnosis and treatment. Semin Fetal Neonatal Med. 20:262–271. 2015. View Article : Google Scholar : PubMed/NCBI
2	Young KC, Torres E, Hehre D, Wu S, Suguihara C and Hare JM: Antagonism of stem cell factor/c-kit signaling attenuates neonatal chronic hypoxia-induced pulmonary vascular remodeling. Pediatr Res. 79:637–646. 2016. View Article : Google Scholar : PubMed/NCBI
3	Shao J, Wang P, Liu A, Du X, Bai J and Chen M: Punicalagin prevents hypoxic pulmonary hypertension via anti-oxidant effects in rats. Am J Chin Med. 44:785–801. 2016. View Article : Google Scholar : PubMed/NCBI
4	Mohsenin V: The emerging role of microRNAs in hypoxia-induced pulmonary hypertension. Sleep Breath. 20:1059–1067. 2016. View Article : Google Scholar : PubMed/NCBI
5	Wang L, Zhou Y, Li M and Zhu Y: Expression of hypoxia-inducible factor-1α, endothelin-1 and adrenomedullin in newborn rats with hypoxia-induced pulmonary hypertension. Exp Ther Med. 8:335–339. 2014. View Article : Google Scholar : PubMed/NCBI
6	Zhou Z, Lu J, Dou J, Lv Z, Qin X and Lin J: FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression. Mol Med Rep. 7:649–653. 2013. View Article : Google Scholar : PubMed/NCBI
7	Malfatti E, Olive M, Taratuto AL, Richard P, Brochier G, Bitoun M, Gueneau L, Laforêt P, Stojkovic T, Maisonobe T, et al: Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders. J Neuropathol Exp Neurol. 72:833–845. 2013. View Article : Google Scholar : PubMed/NCBI
8	Friedrich FW, Wilding BR, Reischmann S, Crocini C, Lang P, Charron P, Müller OJ, McGrath MJ, Vollert I, Hansen A, et al: Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet. 21:3237–3254. 2012. View Article : Google Scholar : PubMed/NCBI
9	Kwapiszewska G, Wygrecka M, Marsh LM, Schmitt S, Trösser R, Wilhelm J, Helmus K, Eul B, Zakrzewicz A, Ghofrani HA, et al: Fhl-1, a new key protein in pulmonary hypertension. Circulation. 118:1183–1194. 2008. View Article : Google Scholar : PubMed/NCBI
10	Vermeulen K, Van Bockstaele DR and Berneman ZN: The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003. View Article : Google Scholar : PubMed/NCBI
11	Brock M, Haider TJ, Vogel J, Gassmann M, Speich R, Trenkmann M, Ulrich S, Kohler M and Huber LC: The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A. Int J Biochem Cell Biol. 61:129–137. 2015. View Article : Google Scholar : PubMed/NCBI
12	Li M, Li Z, Sun X, Yang L, Fang P, Liu Y, Li W, Xu J, Lu J, Xie M and Zhang D: Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells. FEBS J. 277:1543–1550. 2010. View Article : Google Scholar : PubMed/NCBI
13	Zhang D, Wang G, Han D, Zhang Y, Xu J, Lu J, Li S, Xie X, Liu L, Dong L and Li M: Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21 (WAF1): An in vivo study in rats. Life Sci. 98:39–43. 2014. View Article : Google Scholar : PubMed/NCBI
14	Xu XF, Gu WZ, Wu XL, Li RY and Du LZ: Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin. J Matern Fetal Neonatal Med. 24:172–182. 2011. View Article : Google Scholar : PubMed/NCBI
15	Deruelle P, Balasubramaniam V, Kunig AM, Seedorf GJ, Markham NE and Abman SH: BAY 41–2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats. Biol Neonate. 90:135–144. 2006. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Xiang H, Yuan L, Gao X, Alexander PB, Lopez O, Lau C, Ding Y, Chong M, Sun T, Chen R, et al: UHRF1 is required for basal stem cell proliferation in response to airway injury. Cell Discov. 3:170192017. View Article : Google Scholar : PubMed/NCBI
18	Perez KM and Laughon M: Sildenafil in term and premature infants: A systematic review. Clin Ther. 37:2598–2607. 2015. View Article : Google Scholar : PubMed/NCBI
19	Steinhorn RH: Advances in neonatal pulmonary hypertension. Neonatology. 109:334–344. 2016. View Article : Google Scholar : PubMed/NCBI
20	He Y, Cao X, Liu X, Li X, Xu Y, Liu J and Shi J: Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway. Exp Cell Res. 339:122–134. 2015. View Article : Google Scholar : PubMed/NCBI
21	Li L, Wang X, Wang L, Qu L, Zhu X, Li M, Dang X, Li P, Gao Y, Peng Z, et al: Mammalian target of rapamycin overexpression antagonizes chronic hypoxia-triggered pulmonary arterial hypertension via the autophagic pathway. Int J Mol Med. 36:316–322. 2015. View Article : Google Scholar : PubMed/NCBI
22	Umesh A, Paudel O, Cao YN, Myers AC and Sham JS: Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension. J Vasc Res. 48:525–537. 2011. View Article : Google Scholar : PubMed/NCBI
23	Xu YP, Zhu JJ, Cheng F, Jiang KW, Gu WZ, Shen Z, Wu YD, Liang L and Du LZ: Ghrelin ameliorates hypoxia-induced pulmonary hypertension via phospho-GSK3 β/β-catenin signaling in neonatal rats. J Mol Endocrinol. 47:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
24	Yue J, Guan J, Wang X, Zhang L, Yang Z, Ao Q, Deng Y, Zhu P and Wang G: MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1α/Fhl-1 pathway. Lab Invest. 93:748–759. 2013. View Article : Google Scholar : PubMed/NCBI
25	Zhang L, Pu Z and Wang J, Zhang Z, Hu D and Wang J: Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway. Int J Mol Sci. 15:8153–8168. 2014. View Article : Google Scholar : PubMed/NCBI
26	Wedgwood S, Lakshminrusimha S, Schumacker PT and Steinhorn RH: Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn. Front Pharmacol. 6:472015. View Article : Google Scholar : PubMed/NCBI
27	Nadeau S, Baribeau J, Janvier A and Perreault T: Changes in expression of vascular endothelial growth factor and its receptors in neonatal hypoxia-induced pulmonary hypertension. Pediatr Res. 58:199–205. 2005. View Article : Google Scholar : PubMed/NCBI
28	Lin J, Qin X, Zhu Z, Mu J, Zhu L, Wu K, Jiao H, Xu X and Ye Q: FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β. IUBMB Life. 64:921–930. 2012. View Article : Google Scholar : PubMed/NCBI
29	Li Y, Pu G, Chen C and Yang L: Inhibition of FHL1 inhibits cigarette smoke extract-induced proliferation in pulmonary arterial smooth muscle cells. Mol Med Rep. 12:3801–3808. 2015. View Article : Google Scholar : PubMed/NCBI
30	Huetsch JC, Jiang H, Larrain C and Shimoda LA: The Na⁺/H⁺ exchanger contributes to increased smooth muscle proliferation and migration in a rat model of pulmonary arterial hypertension. Physiol Rep. 4:e127292016. View Article : Google Scholar : PubMed/NCBI
31	Wei C, Li HZ, Wang YH, Peng X, Shao HJ, Li HX, Bai SZ, Lu XX, Wu LY, Wang R and Xu CQ: Exogenous spermine inhibits the proliferation of human pulmonary artery smooth muscle cells caused by chemically-induced hypoxia via the suppression of the ERK1/2- and PI3K/AKT-associated pathways. Int J Mol Med. 37:39–46. 2016. View Article : Google Scholar : PubMed/NCBI
32	Yu L, Quinn DA, Garg HG and Hales CA: Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun. 345:1565–1572. 2006. View Article : Google Scholar : PubMed/NCBI
33	Yang Q, Lu Z, Ramchandran R, Longo LD and Raj JU: Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: Role of histone acetylation. Am J Physiol Lung Cell Mol Physiol. 303:L1001–L1010. 2012. View Article : Google Scholar : PubMed/NCBI